Subscribe

Rosemary Frei, MSc

Authored Items

CMS’s Proposed Rule on Part B Drugs Prompts Harsh Response from Oncology Groups
By Rosemary Frei, MSc
May 2016, Vol 6, No 5
Reimbursement
The sharply worded scuffle over the recent Centers for Medicare & Medicaid Services (CMS)’s proposed rule about Medicare Part B payments showcases some of the strong opposing forces at play in the increasingly costly US healthcare system, and the reason why it has been almost impossible to arrive at effective changes. Read More ›
Medicare Will Begin Reimbursing for Advance Care Planning Discussions in 2016
By Rosemary Frei, MSc
December 2015, Vol 5, No 9
Reimbursement
Read More ›
CMS Unveils Equity Plan to Improve Access to Care, Patient Outcomes
By Rosemary Frei, MSc
November 2015, Vol 5, No 8
Health Policy, Practice Management
The Centers for Medicare & Medicaid Services (CMS) Office of Minority Health has released a 19-page plan to address health equity gaps for underserved Medicare beneficiaries, improve their access to care, and measure the success of this undertaking. Read More ›
Countdown to ICD-10 Implementation
By Rosemary Frei, MSc
September 2015, Vol 5, No 6
Reimbursement
Read More ›
Insurance Status Linked to Higher Rates of Certain Cancer Types
By Rosemary Frei, MSc
June 2015, Vol 5, No 5
Read More ›
US Oncologists Favor Establishment of NICE-Like Body to Determine Medicare Reimbursement
By Rosemary Frei, MSc
June 2015, Vol 5, No 5
Reimbursement
According to a recent study, 63.6% of oncologists surveyed favor the establishment of an independent panel of health experts to decide which treatments Medicare will pay for based on a cost-benefit analysis (Gogineni K, et al. J Clin Oncol. 2015;33:846-853). Less than 50% of patients and members of the general public think this is a good idea. The United Kingdom’s National Institute for Health and Care Excellence (NICE) is one model for such a panel. Read More ›
Future of Patient Support Services Offers Challenges, Opportunities
By Rosemary Frei, MSc
June 2015, Vol 5, No 5
Read More ›
Federal Government Outlines Stage 3 of Meaningful Use
By Rosemary Frei, MSc
May 2015, Vol 5, No 4
Reimbursement
Read More ›
340B Rules Remain in Flux
By Rosemary Frei, MSc
May 2015, Vol 5, No 4
Read More ›
Leveraging Data to Improve Cancer Care
By Rosemary Frei, MSc
April 2015, Vol 5, No 3
Big Data
Read More ›
ASCO Shares Concerns Regarding CMS Model
By Rosemary Frei, MSc; Rosemary Frei, MSc
March 2015, Vol 5, No 2
Reimbursement
Read More ›
FDA Issues Final Rule on Pregnancy and Lactation Labeling
By Rosemary Frei, MSc
February 2015, Vol 5, No 1
FDA Approvals, News & Updates
Read More ›
CMS Takes Stock of Federal Health Insurance Marketplace Benefits
By Rosemary Frei, MSc
October 2014, Vol 4, No 6
Practice Management
Read More ›
FDA to Regulate Laboratory-Developed Tests
By Rosemary Frei, MSc
October 2014, Vol 4, No 6
Read More ›
Survey Reveals Drawbacks to Participation in ACA Exchanges
By Rosemary Frei, MSc
August 2014, Vol 4, No 5
Affordable Care Act
Read More ›
Physicians Push to Increase Awareness of Cancer Overdiagnosis and Overtreatment
By Rosemary Frei, MSc
December 2013, Vol 3, No 8
Practice Management
Read More ›
Shift to Hospital-Based Oncology Inadvertently Spurred by the 340B Drug Pricing Program
By Rosemary Frei, MSc
December 2013, Vol 3, No 8
Community Oncology
Read More ›
Institute of Medicine Recommends Measures to Achieve High-Quality Cancer Care
By Rosemary Frei, MSc
December 2013, Vol 3, No 8
Read More ›
Deadline for Approving SGR Reform Legislation Fast Approaching
By Rosemary Frei, MSc
October 2013, Vol 3, No 6
Read More ›
Federal Government Broadens Reimbursement of PET Scans for Cancer Treatment Follow-up
By Rosemary Frei, MSc
October 2013, Vol 3, No 6
Reimbursement
Read More ›
CONNECT
Subscribe
Sign Up for Oncology News

Subscribe to recieve the free, monthly OPM print publication and OPM weekly e‑newsletter.

Subscribe
© The Lynx Group, LLC. All Rights Reserved. Privacy Policy.